Four women receive Brilife COVID vaccination, as Hadassah trials continue
"I have no fear of getting the shot, because I've read up and researched the composition of the vaccine."
25-year-old Sharon Ben Hemo, a fourth-year student at the Faculty of Dentistry of Hadassah and Hebrew University, receives the IIBR's Brilife vaccine as part of the first phase of human trials in Hadassah University Medical Center, 08.11.2020(photo credit: HADASSAH UNIVERSITY MEDICAL CENTER)ByIDAN ZONSHINE
